Navigation Links
Got inexpensive contrast agent? Milk plays new role in imaging

In a new twist on the slogan “milk does a body good,?radiologists are testing use of the dairy staple as a contrast agent in gastrointestinal imaging exams—with excellent results. The researchers reported their findings today at the annual meeting of the Radiological Society of North America (RSNA).

“We are able to achieve similar bowel distension and enhancement as we see with the commonly used contrast agent, VoLumen,?said Lisa R. Shah-Patel, M.D., a radiology resident at St. Luke’s-Roosevelt Hospital in New York City. “In addition, we found that patients are more willing to drink milk because it is part of their daily lives, and they know what to expect.?

Computed tomography (CT) imaging of the gastrointestinal tract is often done for abdominal pain. When the condition calls for visualization of the small intestinal wall, a negative oral contrast agent should be used. VoLumen is a barium-based oral contrast agent that works with intravenous contrast to allow better visualization of the bowel wall and clearer delineation between the bowel cavity and soft tissue.

When milk is used, the milk-filled intestinal cavity appears dark, while the intestinal wall appears bright due to intravenous contrast enhancement. The dark intestinal cavity contrasting with the bright intestinal wall makes any evidence of disease on the bowel wall more visible.

The researchers studied 179 adult patients undergoing CT with oral and intravenous contrast for abdominal discomfort to compare cost effectiveness and patient tolerance for whole milk versus VoLumen. Sixty-two patients received VoLumen, and 117 received milk. Of the 57 VoLumen patients who completed a subsequent questionnaire, 24 (42 percent) experienced abdominal discomfort such as cramps, diarrhea and nausea, while only 27 (23 percent) of the 117 patients who received milk reported abdominal discomfort.

Overall, milk was found to be just as effective as VoLumen in bowel distensio n (expansion) and bowel-wall conspicuity (enhancement). One important difference is the price. VoLumen costs $18 per patient, while whole milk costs $1.39 per patient.

“There are several advantages to milk. Patients are more willing to drink milk than VoLumen, and it costs a fraction of the price,?Dr. Shah-Patel said. “We hope that substituting milk for other contrast agents will reduce the number of people who refuse imaging tests because they do not want to drink the oral contrast, especially children.?
'"/>

Source:Radiological Society of North America


Related biology news :

1. Gadonanotubes greatly outperform existing MRI contrast agents
2. Gallium: A new antibacterial agent?
3. White blood cell waste disposal system plays critical regulatory role
4. Micro-molecule plays big role in birth defects
5. Sleeping beauty plays a significant role in identifying cancer genes
6. Neural stem cell gene plays crucial role in eye development
7. Zinc plays important role in brain circuitry
8. Fish species plays surprise role in aiding coral reef recovery
9. Anticipation plays a powerful role in human memory, brain study finds
10. Motor protein plays key role in connecting neurons
11. Confirmed -- deforestation plays critical climate change role

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/22/2016)... December 22, 2016 SuperCom (NASDAQ: ... solutions for the e-Government, Public Safety, HealthCare, and Finance sectors announced ... has been selected to implement and deploy a community-based supportive services ... Northern California , further expanding its presence in the state. ... This new program, ...
(Date:12/16/2016)... DUBLIN , Dec 16, 2016 Research ... Access System Market - Global Forecast to 2021" report to ... ... projected to grow at a CAGR of 14.06% from 2016 to ... 2016, and is projected to reach 854.8 Million by 2021. The ...
(Date:12/15/2016)... , Dec. 15, 2016 ... driving experience, health wellness and wellbeing (HWW), ... one in three new passenger vehicles begin ... recognition, gesture recognition, heart beat monitoring, brain ... monitoring, facial monitoring, and pulse detection. These ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... , Jan. 18, 2017 Shareholder rights law ... into whether the board members of CoLucid Pharmaceuticals, Inc. ... in connection with the proposed sale of the Company ... company that develops small molecules for the acute treatment ... announced it had signed a definitive merger agreement with ...
(Date:1/18/2017)... TORONTO , Jan. 18, 2017 /PRNewswire/ - ... life sciences and diagnostics company that develops and ... diagnostics ("SQI" or the "Company"), today announced that ... Markets Inc. ("Kingsdale"), has resigned from its Board ... recent changes to securities regulations that have limited ...
(Date:1/17/2017)... Point, IA (PRWEB) , ... January 17, 2017 ... ... from China for Balance™ GT soybeans. The new Balance™ GT Soybean Performance System ... to glyphosate and isoxaflutole, the active ingredient in the new Balance® Bean herbicide. ...
(Date:1/17/2017)... , Jan. 17, 2017 Roka Bioscience, Inc. (NASDAQ: ... advanced testing solutions for the detection of foodborne pathogens today announced ... Ms. Duseau succeeds Paul Thomas , the Company,s President and ... the Company,s Board of Directors.  The changes are effective today. ... Directors, effective today. ...
Breaking Biology Technology: